In this video, Professor Dr. Stefan G. Hofmann emphasizes the importance of considering patient preferences when choosing between pharmacotherapy and psychotherapy for mental health treatment. A stepped approach is recommended, starting with the least risky and most tolerable treatment, often psychotherapy, particularly cognitive behavior therapy. Combining treatments initially is generally not advised due to potential misattribution of benefits and increased relapse rates. Personalized treatment plans should incorporate patient preferences. Recent studies suggest enhancing psychotherapy with agents like psychotherine, which targets extinction learning, a component of exposure therapy, to improve outcomes. 

Professor Dr. Stefan G. Hofmann  
Alexander von Humboldt Professor  
LOEWE Spitzenprofessur für Translationale Klinische Psychologie  
Philipps-Universität Marburg, Germany 

Related content

description Article
An Introduction to Genetics in Anxiety Disorders: Overview and Outlook
20.05.2026 Anxiety Disorders
image Image An overview of methods used within genetic research related to anxiety, including family, twin, linkage, association, GxE, and molecular, cellular and clinical studies.
Overview of approaches used to study the genetics of anxiety disorders
20.05.2026 Anxiety Disorders
image Image graphs showing the impact of anxiety disorders on suicide
The impact of anxiety disorders on suicide

Suicidal ideation is far more common than attempts in people with anxiety or depression, especially with comorbid disorders and severe depression.

08.04.2026 Anxiety Disorders